Zambia’s National Health Insurance Making Progress Towards Strategic Purchasing of Quality Care

On December 9, 2025, the Board of Directors of Zorginstituut Nederland (decision reference 2025027072) approved amendments to the Beleidsregels risicoverevening for 2022, 2023, 2024, and 2025. These changes, published in Staatscourant 2026 nr. 967 on January 19, 2026, correct te...

Navigating a Leaderless Global Economy Through Life Sciences Investment In an era of deepening geopolitical fragmentation, often termed the G-Zero world, global governments are urged to prioritize bold life sci...

Johnson & Johnson has reached a landmark medicine access agreement with the U.S. government, aimed at broadening access to its pharmaceutical products and slashing costs for millions of American patients. Under this voluntary arrangement during the Trump Administration, the company's medicine...